Xiao-Feng Li

Xiao-Feng Li

Auto-generated profile, based on publicly available information

Xiao-Feng Li

State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2020 in Science
Verified
Journal Article
Open access
PDF file
HGHongjing Gu
Hongjing Gu
QCQi Chen
Qi Chen
GYGuan Yang
Guan Yang
LHLei He
Lei He
HFHang Fan
Hang Fan
YZYusen Zhou
Yusen Zhou
Modeling SARS-CoV-2 in mice: Among the research tools necessary to develop medical interventions to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, high on the list are informative animal models with which to study viral pathogenesis. Gu et al. developed a mouse model in which a SARS-CoV-2 strain was infectious and could cause an inflammatory response and moderate pneumonia. Adaptation of this viral strain in the mouse appeared to be dependent on a critical amino acid change, Asn 501 to Tyr (N501Y), within the receptor-binding domain of the viral spike protein. The new mouse model was used to study neutralizing antibodies and a vaccine candidate against the virus. Science , this issue p. 1603

18 September 2020 in Science
Verified
Journal Article
Open access
PDF file
ZLZhe Lv
Zhe Lv
YDYongqiang Deng
Yongqiang Deng
QYQing Qing Ye
Qing Qing Ye
LCLei Cao
Lei Cao
CSChun-Yun Sun
Chun-Yun Sun
XWXiangxi Wang
Xiangxi Wang
A steric block to SARS-CoV-2: In response to infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the immune system makes antibodies, many of which target the spike protein, a key player in host cell entry. Antibodies that potently neutralize the virus hold promise as therapeutics and could inform vaccine design. Lv et al. report a humanized monoclonal antibody that protected against SARS-CoV-2 in a mouse model. The cryo–electron microscopy structure, together with biochemical, cellular, and virological studies, showed that the antibody acts by binding to the receptor-binding domain of the spike and blocking its attachment to the host receptor. Science , this issue p. 1505

26 October 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
GSGuang-Yuan Song
Guang-Yuan Song
XHXing-Yao Huang
Xing-Yao Huang
MHMeng-Jiao He
Meng-Jiao He
HZHang-Yu Zhou
Hang-Yu Zhou
RLRui-Ting Li
Rui-Ting Li
CQCheng-Feng Qin
Cheng-Feng Qin
Increasing evidence shows the African lineage Zika virus (ZIKV) displays a more severe neurovirulence compared to the Asian ZIKV. However, viral determinants and the underlying mechanisms of enhanced virulence phenotype remain largely unknown. Herein, we identify a panel of amino acid substitutions that are unique to the African lineage of ZIKVs compared to the Asian lineage by phylogenetic analysis and sequence alignment. We then utilize reverse genetic technology to generate recombinant ZIKVs incorporating these lineage-specific substitutions based on an infectious cDNA clone of Asian ZIKV. Through in vitro characterization, we discover a mutant virus with a lysine to arginine substitution at position 101 of capsid (C) protein (termed K101R) displays a larger plaque phenotype, and replicates more efficiently in various cell lines. Moreover, K101R replicates more efficiently in mouse brains and induces stronger inflammatory responses than the wild type (WT) virus in neonatal mice. Finally, a combined analysis reveals the K101R substitution promotes the production of mature C protein without affecting its binding to viral RNA. Our study identifies the role of K101R substitution in the C protein in contributing to the enhanced virulent phenotype of the African lineage ZIKV, which expands our understanding of the complexity of ZIKV proteins.

2 May 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
HGHongjing Gu
Hongjing Gu
QCQi Chen
Qi Chen
GYGuan Yang
Guan Yang
LHLei He
Lei He
HFHang Fan
Hang Fan
BSBojiang Shi
Bojiang Shi
Coronavirus disease 2019 (COVID-19) threatens global public health and economy. In order to develop safe and effective vaccines, suitable animal models must be established. Here we report the rapid adaption of SARS-CoV-2 in BALB/c mice, based on which a convenient, economical and effective animal model was developed. Specifically, we found that mouse-adapted SARS-CoV-2 at passage 6 (MACSp6) efficiently infected both aged and young wild-type BALB/c mice, resulting in moderate pneumonia as well as inflammatory responses. The elevated infectivity of MACSp6 in mice could be attributed to the substitution of a key residue (N501Y) in the receptorbinding domain (RBD). Using this novel animal model, we further evaluated the in vivo protective efficacy of an RBD-based SARS-CoV-2 subunit vaccine, which elicited highly potent neutralizing antibodies and conferred full protection against SARS-CoV-2 MACSp6 challenge. This novel mouse model is convenient and effective in evaluating the in vivo protective efficacy of SARS-CoV-2 vaccine. Summary: This study describes a unique mouse model for SARS-CoV-2 infection and confirms protective efficacy of a SARS-CoV-2 RBD subunit vaccine.

14 November 2014 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
JLJuan Liu
Juan Liu
QNQing-Gong Nian
Qing-Gong Nian
JLJing Li
Jing Li
YHYi Hu
Yi Hu
XLXiao-Feng Li
Xiao-Feng Li
CQCheng-Feng Qin
Cheng-Feng Qin
The emerged human infection with avian influenza A (H7N9) virus in China since 2013 has aroused global concerns. There is great demand for simple and rapid diagnostic method for early detection of H7N9 to provide timely treatment and disease control. The aim of the current study was to develop a rapid, accurate and feasible reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay for detection of H7N9 virus. The detection limits of the H7- and N9-specific RT-LAMP assay were both approximately 0.2 PFU per reaction. No cross-reactivity was observed with other subtype of influenza viruses or common respiratory viral pathogens. The assay worked well with clinical specimens from patients and chickens, and exhibited high specificity and sensitivity. The H7/N9 specific RT-LAMP assay was sensitive and accurate, which could be a useful alternative in clinical diagnostics of influenza A (H7N9) virus, especially in the hospitals and laboratories without sophisticated diagnostic systems.

24 June 2016 in Virology Journal
Verified
Journal Article
Open access
PDF file
JWJinliang Wang
Jinliang Wang
JYJie Yang
Jie Yang
JGJingying Ge
Jingying Ge
Rong-Hong HuaRong-Hong Hua
Rong-Hong Hua
RLRenqiang Liu
Renqiang Liu
ZBZhigao Bu
Zhigao Bu
West Nile virus (WNV) is an emerging zoonotic pathogen which is harmful to human and animal health. Effective vaccination in susceptible hosts should protect against WNV infection and significantly reduce viral transmission between animals and from animals to humans. A versatile vaccine suitable for different species that can be delivered via flexible routes remains an essential unmet medical need. In this study, we developed a recombinant avirulent Newcastle disease virus (NDV) LaSota strain expressing WNV premembrane/envelope (PrM/E) proteins (designated rLa-WNV-PrM/E) and evaluated its immunogenicity in mice, horses, chickens, ducks and geese. Mouse immunization experiments disclosed that rLa-WNV-PrM/E induces significant levels of WNV-neutralizing antibodies and E protein-specific CD4+ and CD8+ T-cell responses. Moreover, recombinant rLa-WNV-PrM/E elicited significant levels of WNV-specific IgG in horses upon delivery via intramuscular immunization, and in chickens, ducks and geese via intramuscular, oral or intranasal immunization. Our results collectively support the utility of rLa-WNV-PrM/E as a promising WNV veterinary vaccine candidate for mammals and poultry.